Glaxosmithkline Intellectual Property Development Limited

Royaume‑Uni


 
Quantité totale PI 743
Rang # Quantité totale PI 1 768
Note d'activité PI 3,3/5.0    415
Rang # Activité PI 1 717
Parent GlaxoSmithKline plc
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

226 0
109 0
403 5
0
 
Dernier brevet 2025 - Cytotoxicity targeting chimeras ...
Premier brevet 2006 - Enzyme and receptor modulation
Dernière marque 2000 - Keppra levetiracetam
Première marque 1999 - KEPPRA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention 5,6,7,7a-tetrahydrocyclopenta[f]pyrido[1,2-h][1,7] naphthyridin-11(4bh)-one compounds and methods...
Invention Il-7 binding proteins and their use in medical therapy. Provided herein are interleukin 7 (IL-7)...
Invention Cytotoxicity targeting chimeras for fibroblast activation protein-expressing cells. The present ...
Invention Cytotoxicity targeting chimeras for prostate specific membrane antigen-expressing cells. The pre...
Invention Cytotoxicity targeting chimeras for folate receptor-expressing cells. The present disclosure rel...
Invention Cytotoxicity targeting chimeras for ccr2-expressing cells. The present disclosure relates to het...
Invention Cytotoxicity targeting chimeras for cxcr3-expressing cells. The present disclosure relates to he...
Invention Heterocyclic compounds and their use in the treatment of mycobacterial infections. The invention ...
Invention Pi4kiiibeta inhibitors. The invention relates to compounds of formula (I) which are inhibitors o...
Invention Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an ...
Invention Compounds. The present invention relates to novel compounds that inhibit Lp-PLA2 activity, proce...
Invention Cytotoxicity targeting chimeras for car-t and car-nk cells. The present disclosure relates to het...
Invention Cytotoxicity targeting chimeras for antibody-drug conjugates and bispecific antibodies. The prese...
Invention Bispecific cytotoxicity targeting chimeras. The present disclosure relates to heterotrifunctional...
Invention Methods of treating chronic hepatitis b. The present disclosure relates to methods for treating a...
Invention Biopharmaceutical compositions and related methods. The present disclosure relates to compositio...
Invention System. The present invention relates to novel systems, polypeptides, compounds and methods. The ...
Invention Hydroxypyridoxazepines as nrf2 activators. The present invention relates hydroxypyridoxazepine c...
Invention Triazole-substituted imidazo[1,2-a]pyrimidines as cgas inhibitors. The present invention relates...
Invention Methods of treating atopic dermatitis. The disclosure provides a method of treating atopic dermat...
2023 Invention Method of treating pain with an anti-ccl17 antibody. A method for treating chronic pain in a huma...
Invention Methods of treatment using b-cell maturation antigen antagonists. The disclosure provides methods...
Invention Treatment regimen. The present invention relates to a novel treatment method for the treatment o...
Invention Compounds useful in hiv therapy. The invention relates to compounds of Formula (I), (Ia), (II) o...
Invention Method for predicting production stability of clonal cell lines. The invention relates to a metho...
Invention Reduction or prevention of a malaria parasite or dengue virus transmission with 1 -methyl-9h-pyri...
Invention Reducing disease transmission of vector borne diseases. The present application relates to compou...
Invention Triazole-substituted imidazo[1,2-a]pyrimidines as cgas inhibitors. The present invention relates ...
Invention Gepotidacin for use in the treatment of bacterial prostatitis. The present invention relates to m...
Invention Il-7 binding proteins and their use in medical therapy. Provided herein are interleukin 7 (IL-7) ...
Invention Antigen binding proteins and uses thereof. PlasmodiumPlasmodiumPlasmodium circumsporozoite protei...
Invention Anti-bcma antibody drug conjugate combination treatment for cancer. Disclosed herein is a method ...
Invention Novel use. The present disclosure relates to an inhibitor of GPR91 for use in the treatment or p...
Invention Gepotidacin formulation. An oral formulation of, or comprising, granules of active pharmaceutical...
Invention Substituted pyridines as dnmt1 inhibitors. The invention relates to substituted pyridine derivat...
Invention Methods for purifying recombinant polypeptides. The present invention is directed to a novel proc...
Invention Chemical compounds. Provided are compounds and pharmaceutical compositions and uses thereof for ...
Invention Chemical compounds. vvv1.8 mediated diseases, such as pain and pain-associated diseases, and card...
Invention Nitrogen containing condensed 2,3-dihydroquinazolinone compounds as nav1.8 inhibitors. Small mole...
2022 Invention Interleukin 5 binding protein dosage regimen for use in treating polyangiitis, hypereosinophilic ...
Invention Display screen with graphical user interface
Invention Compounds useful in hiv therapy. The invention relates to compounds of Formula (I), (Ia), (Ib), ...
Invention Biopharmaceutical compositions and stable isotope labeling peptide mapping method. Disclosed her...
Invention Pharmaceutical compound. The present application relates to compounds of Formula (I) or a pharma...
Invention Oral solid dose formulations. Disclosed are novel pharmaceutical compositions comprising gepotid...
2021 Invention Interleukin 5 binding protein dosage regimen. The present disclosure relates to pharmaceutical c...
Invention Nitrogen containing 2,3-dihydroquinazolinone compounds as nav1.8 inhibitors. Compounds of formul...
Invention Cathepsin inhibitors for preventing or treating viral infections. Provided are cathepsin inhibit...
2018 Invention Novel processes for the production of oligonucleotides. The invention relates to novel processes...
2002 P/S Pharmaceutical, veterinary and sanitary products; dietetic substances for medical use, food for ...
2000 P/S Pharmaceutical products and specialties acting on the central nervous system.